Cote d’Ivoire Ensures HIV/AIDS Care Amid U.S. Aid Suspension

Cote d’Ivoire’s healthcare for HIV/AIDS is assured despite the U.S. funding suspension. The government has implemented contingency plans to maintain ARV supplies and access to treatment. Progress in the fight against HIV/AIDS has been significant, with a notable reduction in mortality and prevalence rates.

In early February, United States President Donald Trump announced the closure of the U.S. Agency for International Development (USAID), which had previously pledged $115 million in aid for Cote d’Ivoire in 2024. Since 2008, HIV/AIDS care has been provided free of charge in the country. Despite these changes, the Ivorian Ministry of Health has assured that care for individuals living with HIV remains “fully guaranteed.”

In a statement, the health ministry responded to concerns about a potential shortage of antiretrovirals (ARVs) due to the funding suspension, emphasizing that ARV supplies are secure. “The supply of ARVs is assured,” the ministry confirmed, pointing out that there will be no disruptions in treatment. A contingency plan has been activated to maintain continuity of care for citizens affected by HIV.

Currently, the available ARV stock is sufficient to meet needs for the next four months, supported by a comprehensive monitoring system to avert shortages. Additionally, a financing mechanism has been established to diminish any adverse effects resulting from the cessation of external funding. The government is committed to ensuring consistent access to treatment, screening, and patient support services.

Cote d’Ivoire is home to about 400,000 individuals living with HIV as of 2024. The country has successfully reduced mortality rates connected to HIV/AIDS by 70% since 2010, alongside a decrease in prevalence from 2.4% to 1.8% over the same period. This progress signifies effective measures in combating the virus despite recent disruptions in aid.

In summary, the Ministry of Health of Cote d’Ivoire has committed to ensuring continued care and access to antiretroviral therapy for individuals living with HIV, despite the recent suspension of significant U.S. funding. The effectiveness of the country’s health policies is evident in its substantial progress against HIV/AIDS, showcasing a strong commitment to public health.

Original Source: eastleighvoice.co.ke